Journal Information
Vol. 43. Issue S3.
Pages S61-S62 (November 2021)
Share
Share
Download PDF
More article options
Vol. 43. Issue S3.
Pages S61-S62 (November 2021)
PP 76
Open Access
A NOVEL MISSENSE MUTATION OUTSIDE DNAJ DOMAIN OF DNAJC21 IS ASSOCIATED WITH SHWACHMAN-DIAMOND SYNDROME
Visits
942
Mohammad Bilal Alsavaf1, Jeffrey M. Verboon2, Muhammed E. Dogan3, Zehra Busra Azizoglu4, Fatma Zehra Okus1, Alper Ozcan1, Munis Dundar3, Ahmet Eken4, Hamiyet Donmez Altıuntas5, Vijay G. Sankaran2, Ekrem Unal1
1 Division of Pediatric Hematology, Oncology & HSCT Center, Department of Pediatrics, Erciyes University, Faculty of Medicine
2 Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston
3 Department of Medical Genetic, Erciyes University
4 Gevher Nesibe Genom and Stem Cell Institution, Betul Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University, Faculty of Medicine
5 Department of Medical Biology, Erciyes University, Faculty of Medicine
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 43. Issue S3
More info

Shwachman-Diamond Syndrome (SDS) and related bone marrow failure disorders are characterized by early onset pancytopenia with a hypocellular bone marrow, short stature, and pancreatic insufficiency, along with an increased risk for myeloid malignancies. Recently, several cases with an SDS-like syndrome have been reported to harbor mutations in the DNAJ domain of DNAJC21. Here, we report an intriguing case of a 13.5 years-old female born to Turkish consanguineous parents with a novel missense mutation occurring outside the DNAJ domain of the DNAJC21 gene. Whole-exome and Sanger sequencing confirmation revealed a homozygous missense mutation in DNAJC21 gene c.463T>C, p.W155R which was considered as pathogenic in in silico analyses. Initially, this patient's vague and atypical symptoms led to uncertainty of the underlying diagnosis. Upon confirmation of the genetic mutation, a number of functional studies such as diepoxibutane test, proliferation test from peripheral blood mononuclear cells, and cytokinesis-block micronucleus cytome assay performed with the patient cells confirmed the likely diagnosis of an SDS-like syndrome attributable to DNAJC21 dysfunction. Through the analysis of this rare case, we illuminate the pleiotropic features of this unique bone marrow failure syndrome and emphasize the paramount role of genomic testing to discriminate a range of closely related bone marrow failure disorders.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools